Specific targeting of the IL-23 receptor, using a novel small peptide noncompetitive antagonist, decreases the inflammatory response.
Quiniou C, Domínguez-Punaro M, Cloutier F, Erfani A, Ennaciri J, Sivanesan D, Sanchez M, Chognard G, Hou X, Rivera JC, Beauchamp C, Charron G, Vilquin M, Kuchroo V, Michnick S, Rioux JD, Lesage S, Chemtob S.
Quiniou C, et al.
Am J Physiol Regul Integr Comp Physiol. 2014 Nov 15;307(10):R1216-30. doi: 10.1152/ajpregu.00540.2013. Epub 2014 Aug 20.
Am J Physiol Regul Integr Comp Physiol. 2014.
PMID: 25354400
Free article.